STOCKSCOPE

Nufarm (ASX: NUF) Delivers 25% Earnings Growth as Stronger Cash Flow and Seed Expansion Fuel Turnaround

Mark Elzayed

Mark Elzayed

CIO at Vestra Capital

Published:2d ago
Nufarm (ASX: NUF) Delivers 25% Earnings Growth as Stronger Cash Flow and Seed Expansion Fuel Turnaround

Nufarm Limited (ASX: NUF) is building momentum after delivering a 25% increase in underlying earnings, positive free cash flow and a stronger balance sheet in FY26. With its Seed Technologies division expanding rapidly and restructuring benefits beginning to emerge, the agricultural chemicals group is showing encouraging signs of a sustained financial recovery.

The key question now is whether Nufarm can build on this progress and translate improving operational performance into stronger profitability and shareholder value.

Key Numbers: Nufarm's FY26 Financial Recovery

  • $378.3 million underlying EBITDA, up 25% for the year ended 30 September 2026.
  • $19.9 million underlying net profit after tax, reversing a $22.9 million loss in FY25.
  • $28 million positive free cash flow, representing a $158 million year-on-year improvement.
  • $749 million net debt, down 9%, with leverage improving from 2.7 times to 2.0 times.
  • $448.8 million Seed Technologies revenue, up 34%, with divisional EBITDA reaching $86.4 million.

Stronger Earnings Signal a More Efficient Business

Nufarm's FY26 results highlight the benefits of its ongoing operational transformation.

Despite group revenue declining approximately 7% to $3.21 billion, underlying EBITDA increased to $378.3 million, reflecting improved margins, disciplined cost management and a greater focus on higher-value products.

Underlying EBIT more than doubled to $165.2 million, while return on funds employed improved from 2.8% to 5.9%.

These improvements suggest Nufarm is becoming more efficient at converting revenue into operating earnings.

Although the company recorded a statutory net loss of $79.5 million, including $99.4 million in after-tax material items, much of the adjustment related to restructuring activities.

We see the improvement in underlying profitability as an encouraging indication that management's efforts to simplify the business are gaining traction.

Seed Technologies Emerges as a Powerful Growth Driver

One of the standout developments was the performance of Nufarm's Seed Technologies division.

Divisional EBITDA increased by $72.5 million to $86.4 million, supported by strong canola seed demand and improving Renewable Oils contributions.

The Seeds business generated $292.8 million in revenue, increasing 16%, while EBITDA climbed 22% to $81.8 million.

Growth across Australian and South American canola markets demonstrates the commercial strength of Nufarm's seed portfolio.

Renewable Oils also returned to positive EBITDA of $4.6 million, supported by improved Omega-3 pricing conditions.

Meanwhile, Crop Protection delivered $364.6 million in EBITDA despite challenging market conditions, with margins improving by 1.3 percentage points.

Importantly, net working capital declined 12% to $777.8 million, helping improve cash conversion and reduce financial pressure.

We think these developments demonstrate that Nufarm's growth opportunities are becoming better supported by operational and financial discipline.

What Nufarm Is Doing Now

Nufarm continues to reshape its operations around profitability, efficiency and higher-return opportunities.

The company has removed approximately 280 products and pack sizes from its North American portfolio, reducing complexity and strengthening its product mix.

It is also progressing manufacturing facility closures at Kwinana in Western Australia and Alsip in the United States.

Its restructuring programme targets $50 million in annualised cost savings by the end of FY27, providing a potential foundation for further margin improvements.

Within Renewable Oils, Nufarm has extended its carinata offtake agreement with bp until 2050, supporting long-term commercial opportunities in sustainable biofuel feedstocks.

These initiatives position the company to pursue growth while maintaining greater control over operating expenditure and capital requirements.

Insight: Is Nufarm Building a More Profitable Future?

We think Nufarm's FY26 performance marks an encouraging step towards a stronger and more sustainable business. The combination of expanding seed earnings, improving cash generation and declining leverage supports growing confidence in its operational recovery. Its Seed Technologies portfolio offers attractive growth potential, while restructuring savings could strengthen margins further. Although financing costs, remaining debt and modest returns on capital require continued attention, the direction of financial performance is positive. We believe sustained free cash flow generation and disciplined capital allocation will be the clearest indicators of whether this recovery can create lasting shareholder value.

What Happens Next?

Nufarm expects further underlying EBITDA growth in FY27, including mid-teens growth in Seed Technologies and mid-single-digit growth in Crop Protection, subject to seasonal and currency conditions.

Management also anticipates capital expenditure below $200 million, improving free cash flow and further reductions in net debt.

The company's leverage target of 1.5 to 2.0 times provides another measurable indicator of financial progress.

The next important milestone will be delivering restructuring savings while maintaining momentum across its core operations.

With stronger earnings, an expanding seed business and improving financial flexibility, Nufarm enters FY27 with a more encouraging outlook and an opportunity to demonstrate that its turnaround can deliver sustainable profitability.

Mark Elzayed

Mark Elzayed

(CIO at Vestra Capital)

Mark Elzayed is a prominent Australian financial executive and portfolio strategist with over a decade of hands-on capital markets experience. Having successfully managed over $100M+ in FUM across volatile economic cycles, Mark founded Vestra Capital to democratize institutional-grade quantitative strategies and privileged ASX deal flow for Australian investors.

DisclaimerInformation on Stockscope is general in nature and does not constitute financial product advice. It does not take into account your personal objectives, financial situation or needs. Seek independent advice from a qualified financial adviser before making an investment decision. Stockscope and its affiliates do not guarantee the accuracy or completeness of information published on this website. To the extent permitted by law, they accept no liability for any claim, loss or damage arising from its use or reliance on it. Stockscope and its associates may have commercial relationships with companies featured on this website, hold securities in those companies, or receive commissions in connection with capital raisings.

Continue Reading

ASX slides to five-month low as AI sell-off rattles global markets
Market Briefings
Market Briefings

ASX slides to five-month low as AI sell-off rattles global markets

Australian equities: what moved the ASX 200? Australian shares extended their losing streak on Friday, with the S&P/ASX 200 falling 137.8 points, or 1.58%, to close at 8,592.6. This marked...

Mark ElzayedMark Elzayed•
NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play
Technology
Technology

NEXTDC (ASX: NXT) Raises FY27 Earnings Outlook as $140 Million Melbourne Opportunity Remains in Play

NEXTDC Limited ASX: NXT has delivered an encouraging upgrade to its FY27 earnings guidance, highlighting the strength of its broader data centre business despite electricity supply delays at...

Danny AadDanny Aad•
Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential
Mining
Mining

Trek Metals (ASX: TKM) Hits 40.3% Manganese at Kuro as High-Grade Discovery Opens Up Bigger Potential

A standout 25-metre intersection grading 31.4% manganese has delivered another encouraging result for Trek Metals Limited ASX: TKM, strengthening the exploration potential of its Kuro discov...

Alison ElzayedAlison Elzayed•
EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges
Biotech & Health
Biotech & Health

EBR Systems (ASX: EBR) Moves Closer to US-Wide Medicare Coverage as Major Growth Opportunity Emerges

EBR Systems ASX: EBR has taken another significant step towards expanding the commercial reach of its wireless heart pacing technology, with US Medicare authorities proposing national covera...

Danny AadDanny Aad•
Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches
Mining
Mining

Orion Minerals (ASX: ORN) Unlocks US$6.7 Million From Glencore as Major Copper Production Milestone Approaches

Orion Minerals ASX: ORN has reached a significant turning point in its copper and zinc development strategy, receiving its first US$6.7 million payment from global mining group Glencore. The...

Alison ElzayedAlison Elzayed•
EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development
Biotech & Health
Biotech & Health

EMVision Medical Devices (ASX: EMV) Unlocks a 1,700-Hospital Opportunity as Fresh Funding Accelerates Stroke Scanner Development

EMVision Medical Devices ASX: EMV is building momentum towards a potentially significant commercial breakthrough, with a fresh $306,750 government grant payment supporting the expansion of i...

Danny AadDanny Aad•
Loading more stories...